(no text — see the shared post below)
No randomized trial shows ezetimibe alone lowers heart attack or stroke risk
Louis warns against stopping a statin for ezetimibe monotherapy because no randomized trial has shown ezetimibe alone reduces events. It is usually prescribed in addition to statins.



